GEODE CAPITAL MANAGEMENT, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,069,969
+47.0%
219,127
+8.6%
0.00%
Q2 2023$2,087,812
+1471.7%
201,721
+1303.2%
0.00%
Q1 2023$132,834
+104493.7%
14,3760.0%0.00%
Q4 2022$127
-99.9%
14,3760.0%0.00%
Q3 2022$119,000
+1.7%
14,3760.0%0.00%
Q2 2022$117,000
-92.4%
14,376
-91.8%
0.00%
Q1 2022$1,534,000
-3.8%
176,213
+5.0%
0.00%
Q4 2021$1,595,000
-38.5%
167,757
+8.8%
0.00%
Q3 2021$2,593,000
+2.6%
154,185
-6.9%
0.00%
Q2 2021$2,528,000
-21.4%
165,595
+0.3%
0.00%
Q1 2021$3,217,000
+21.8%
165,165
+12.6%
0.00%
Q4 2020$2,642,000
-7.8%
146,642
-1.3%
0.00%
-100.0%
Q3 2020$2,866,000
-26.3%
148,605
-0.2%
0.00%0.0%
Q2 2020$3,889,000
+58.5%
148,917
+8.2%
0.00%0.0%
Q1 2020$2,454,000
-70.0%
137,585
-43.9%
0.00%0.0%
Q4 2019$8,178,000
+212.7%
245,088
+123.3%
0.00%0.0%
Q3 2019$2,615,000
-30.1%
109,764
+5.5%
0.00%0.0%
Q2 2019$3,739,000
+550.3%
104,050
+568.1%
0.00%
Q1 2019$575,000
-17.6%
15,575
-4.2%
0.00%
Q4 2018$698,000
+82.2%
16,250
+100.0%
0.00%
Q3 2018$383,000
+7.9%
8,125
+13.7%
0.00%
Q2 2018$355,0000.0%7,1450.0%0.00%
Q1 2018$355,000
+34.0%
7,1450.0%0.00%
Q4 2017$265,000
+17.8%
7,1450.0%0.00%
Q3 2017$225,0007,1450.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders